PUBLISHER: The Business Research Company | PRODUCT CODE: 1712352
PUBLISHER: The Business Research Company | PRODUCT CODE: 1712352
Cardiovascular medical lasers play a crucial role in treating heart-related medical conditions, particularly during transmyocardial laser revascularization procedures.
The market for cardiovascular medical lasers, as detailed in this report, is divided into excimer lasers and carbon dioxide lasers. Carbon dioxide lasers are instrumental in precisely removing thin skin layers with minimal impact on surrounding tissues. These lasers find applications in various procedures, including laser vascular anastomosis, transmyocardial laser revascularization, and laser angioplasty for peripheral arterial diseases. They are employed by end users like hospitals, specialized clinics, and ambulatory surgery centers.
The cardiovascular medical lasers market research report is one of a series of new reports from The Business Research Company that provides cardiovascular medical lasers market statistics, including cardiovascular medical lasers industry global market size, regional shares, competitors with a cardiovascular medical lasers market share, detailed cardiovascular medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular medical lasers industry. The cardiovascular medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiovascular medical lasers market size has grown exponentially in recent years. It will grow from $0.31 billion in 2024 to $0.45 billion in 2025 at a compound annual growth rate (CAGR) of 45.6%. The growth in the historic period can be attributed to growing demand for minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, rising disposable incomes, growing adoption of telemedicine in cardiology,.
The cardiovascular medical lasers market size is expected to see exponential growth in the next few years. It will grow to $1.71 billion in 2029 at a compound annual growth rate (CAGR) of 40.0%. The growth in the forecast period can be attributed to advanced robotics, cardiovascular research, aging population, personalized cardiovascular care, expansion of interventional cardiology. Major trends in the forecast period include advanced laser fiber technology, ai-powered telehealth, smart laser systems, laser-induced regeneration, sustainable laser technologies, integration of advanced imaging.
The anticipated growth in the cardiovascular medical laser market is attributed to the expanding prevalence of cardiovascular diseases, which can be linked to factors like increased smoking rates, sedentary lifestyles, and poor dietary habits. As reported by the Centers for Disease Control and Prevention in May 2023, coronary artery disease (CAD) led to the demise of 375,476 individuals in 2021, affecting approximately 1 in 20 adults aged 20 and above. Furthermore, nearly 2 in 10 CAD-related deaths occurred among individuals younger than 65 years old. This rising prevalence of cardiovascular diseases is poised to be a significant driver behind the growth of the cardiovascular medical laser market.
The anticipated growth in the cardiovascular medical lasers market is primarily driven by the increasing occurrences of diabetes and obesity. These medical conditions lead to higher levels of blood glucose and a higher body mass index. Cardiovascular medical lasers are essential tools in treating the vascular complications associated with both diabetes and obesity, particularly in procedures such as angioplasty and atherectomy. They're also utilized in obesity management surgeries and for treating diabetic retinopathy. As reported by the International Diabetes Federation in June 2022, the global diabetes prevalence stands at 10.5%, with approximately 44.7% of affected individuals remaining undiagnosed. Predictions suggest a steep increase in the diabetic population to 783 million by 2045, a 46% surge over the current figures. Moreover, the World Health Organization indicated in March 2022 that obesity affects a considerable number of people-650 million adults, 340 million teenagers, and 39 million children, with the prevalence continuing to rise. By 2025, an estimated 167 million more individuals will likely fall into the overweight or obese category. As a result, the growing occurrences of diabetes and obesity are pivotal drivers behind the expansion of the cardiovascular medical lasers market.
Manufacturers in the cardiovascular medical laser industry continue to invest in cutting-edge technologies aimed at expedited diagnosis and effective treatment of heart conditions. Technological enhancements encompass a range of developments such as new wavelengths, more robust setups, cost-effective systems, and other innovations integrated with minimally invasive procedures. Ra Medical obtained FDA clearance for its vascular products, inclusive of cardiovascular lasers specifically designed for treating peripheral arteries and veins. The lasers function at a 308-nanometer wavelength, breaking down chemical bonds and disintegrating blockages, ultimately reducing patient risk.
Major companies in the cardiovascular medical laser market are focusing on developing non-invasive technologies, such as specialized lasers, to enhance treatment efficacy and improve patient safety. These innovations are designed to optimize treatment outcomes for conditions like atherosclerosis and varicose veins. Specialized lasers are engineered with specific characteristics, such as wavelength and output power, to suit targeted medical applications. These lasers are commonly used in various fields, including medicine, manufacturing, and telecommunications. For example, in May 2024, Aster Medcity, Kerala's first quaternary care hospital in India, introduced Excimer laser angioplasty. This minimally invasive procedure is used to treat complex cardiovascular conditions by modifying and removing arterial plaque. Its advantages include higher success rates, reduced tissue damage, and shorter recovery times.
In August 2024, JC Medical Inc., a U.S.-based medical equipment supplier, acquired Edwards Lifesciences for an undisclosed amount. Through this acquisition, JC Medical Inc. aims to enhance its innovative J-Valve system, which treats severe symptomatic native aortic regurgitation, while leveraging Edwards Lifesciences' resources to expand product development and market reach. The focus is on addressing unmet patient needs in the structural heart disease space. Edwards Lifesciences, a U.S.-based technology company, specializes in innovative heart valve technologies, while cardiovascular medical lasers contribute to enhanced precision in procedures such as angioplasty and valve replacements.
Major companies operating in the cardiovascular medical lasers market include Boston Scientific Corporation, Cardiovascular Systems Inc., AngioDynamics Inc., Koninklijke Philips N.V., RA Medical Systems Inc., Abbott Laboratories Inc., Alma Lasers Inc., B. Braun Melsungen AG, Bausch + Lomb Incorporated, Biolase Inc., Candela Medical Corporation, Cutera Inc., DEKA Research & Development Corporation, Edwards Lifesciences Corporation, EUFOTON S.P.A., Fotona d.d., Gigaa Laser Group, IRIDEX Corporation, Lumenis Ltd., Medtronic Inc., Novartis AG, PhotoMedex Inc., Quanta System S.p.A, Sciton Inc., Stryker Corporation, Terumo Corporation, TransEnterix Inc., Vascular Solutions Inc., Zimmer Biomet Holdings Inc.
North America was the largest region in the cardiovascular medical lasers market in 2024. Asia-Pacific was the second-largest region in the global cardiovascular medical lasers market report. The regions covered in the cardiovascular medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the cardiovascular medical lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The cardiovascular medical lasers market consists of sales of instruments such as excimer lasers and carbon dioxide lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiovascular Medical Lasers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cardiovascular medical lasers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiovascular medical lasers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiovascular medical lasers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.